ARTICLE | Distillery Therapeutics
Pulmonary
November 6, 2017 8:32 PM UTC
Patient sample, mouse and cell culture studies suggest inhibiting miR-34a could help treat BPD and acute lung injury (ALI) in neonates. In postmortem lung tissue samples from premature infants with BP...
BCIQ Company Profiles
BCIQ Target Profiles